{"id":52311,"date":"2026-03-25T20:00:00","date_gmt":"2026-03-25T13:00:00","guid":{"rendered":"https:\/\/thaipropertynews.com\/feeds\/?p=52311"},"modified":"2026-03-25T20:00:00","modified_gmt":"2026-03-25T13:00:00","slug":"k-beauty-manufacturer-km-pharmaceutical-kosdaq-225430-expands-global-skincare-and-oral-care-oem-odm-platform-with-advanced-functional-product-portfolio","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=52311","title":{"rendered":"K-Beauty Manufacturer KM Pharmaceutical (KOSDAQ: 225430) Expands Global Skincare and Oral Care OEM\/ODM Platform with Advanced Functional Product Portfolio"},"content":{"rendered":"<p><span class=\"legendSpanClass\">SEOUL, South Korea<\/span>, <span class=\"legendSpanClass\">March 25, 2026<\/span> \/PRNewswire\/ &#8212; KM Pharmaceutical Co., Ltd. (KOSDAQ: 225430), a leading K-beauty manufacturer specializing in skincare, oral care, and private label OEM\/ODM production, is strengthening its global position by expanding into high-value functional product categories across haircare, skincare, and oral care.<\/p>\n<p>Expansion into High-Value Functional Product Categories<\/p>\n<p>KM Pharmaceutical is strategically expanding its product portfolio to focus on functional and OTC-driven categories with strong global demand.<\/p>\n<p>In haircare, the company is developing products targeting:<\/p>\n<ul type=\"disc\">\n<li>Hair loss symptom relief (functional scalp care)<\/li>\n<li>Scalp inflammation soothing<\/li>\n<li>Scalp barrier strengthening<\/li>\n<\/ul>\n<p>In skincare, the company is strengthening its functional cosmetic lineup with:<\/p>\n<ul type=\"disc\">\n<li>Brightening (whitening) solutions<\/li>\n<li>Anti-wrinkle and firming products<\/li>\n<li>Skin barrier repair and strengthening<\/li>\n<li>Anti-inflammatory and soothing formulations for sensitive skin<\/li>\n<\/ul>\n<p>In oral care, KM Pharmaceutical is expanding its OTC-focused portfolio with:<\/p>\n<ul type=\"disc\">\n<li>Teeth whitening solutions<\/li>\n<li>Gum disease prevention products<\/li>\n<li>Gingivitis and\u00a0periodontitis prevention formulations<\/li>\n<\/ul>\n<p>These categories reflect the company&#8217;s strategic direction toward high-efficacy, clinically positioned products that align with global consumer demand for functional and results-driven personal care.<\/p>\n<p>Dual-Facility Manufacturing Platform Supporting\u00a0Skincare and OTC Production<\/p>\n<p>KM Pharmaceutical operates two specialized production facilities in Korea:<\/p>\n<ul type=\"disc\">\n<li>An OTC manufacturing facility focused on oral care products, including toothpaste and functional personal care<\/li>\n<li>A cosmetics manufacturing facility dedicated to\u00a0skincare and beauty product development<\/li>\n<\/ul>\n<p>This infrastructure enables the company to deliver both cosmetic and OTC products under one integrated system, supporting global partners seeking scalable and compliant manufacturing solutions.<\/p>\n<p>Rapid Expansion in\u00a0Skincare OEM\/ODM with International Contracts<\/p>\n<p>Skincare continues to be a key growth driver for KM Pharmaceutical&#8217;s global business.<\/p>\n<p>The company recently secured:<\/p>\n<ul type=\"disc\">\n<li>A\u00a0KRW 1 billion annual skincare supply agreement with General Brands<\/li>\n<li>A new\u00a0skincare manufacturing partnership with Thailand-based ADMI<\/li>\n<li>Ongoing collaborations with multiple domestic and international partners<\/li>\n<\/ul>\n<p>Proven Global Manufacturing Experience with Leading Brands<\/p>\n<p>KM Pharmaceutical has established strong credibility through partnerships with globally recognized brands.<\/p>\n<p>The company has:<\/p>\n<ul type=\"disc\">\n<li>Produced oral care products under an exclusive long-term license for\u00a0Pororo the Little Penguin<\/li>\n<li>Manufactured and distributed products in Korea for\u00a0TheraBreath<\/li>\n<li>Previously manufactured toothpaste for Close-Up under\u00a0Unilever<\/li>\n<li>Currently producing toothpaste for\u00a0Weleda<\/li>\n<\/ul>\n<p>Fully Integrated\u00a0K-Beauty Manufacturing Platform<\/p>\n<p>KM Pharmaceutical operates a vertically integrated system covering:<\/p>\n<ul type=\"disc\">\n<li>R&amp;D and formulation<\/li>\n<li>OEM\/ODM manufacturing<\/li>\n<li>Packaging and mass production<\/li>\n<li>Global export and supply<\/li>\n<\/ul>\n<p>This end-to-end capability enables faster time-to-market, consistent quality, and scalable production for international partners.<\/p>\n<p>25 Years of Experience with Public Market Transparency<\/p>\n<p>Founded in 2001, KM Pharmaceutical has over 25 years of manufacturing experience.<\/p>\n<p>Since its KOSDAQ listing in 2018, the company has maintained audited financial transparency and governance aligned with public market standards.<\/p>\n<p>Internal Brand Success Demonstrating Product Competitiveness<\/p>\n<p>KM Pharmaceutical continues to validate its R&amp;D capabilities through its proprietary brands.<\/p>\n<p>Zerocipe, the company&#8217;s flagship brand, achieved the No.1 ranking in the shampoo category at Olive Young, recording peak daily sales exceeding KRW 100 million.<\/p>\n<p>The company has also expanded internationally through a distribution partnership with Cosway, targeting Southeast Asian markets.<\/p>\n<p>Balanced Growth Strategy: Recurring Revenue + Brand Upside<\/p>\n<p>KM Pharmaceutical is executing a dual-track strategy:<\/p>\n<ul type=\"disc\">\n<li>B2B Growth: Expanding OEM\/ODM partnerships<\/li>\n<li>B2C Expansion: Scaling proprietary brands through global channels<\/li>\n<\/ul>\n<p>Positioned as a Scalable Global Functional Beauty &amp; OTC Platform<\/p>\n<p>Brian Baik, CEO of KM Pharmaceutical stated:<\/p>\n<p>&#8220;KM Pharmaceutical is evolving beyond a traditional OEM\/ODM manufacturer into a functional beauty and OTC platform. By combining clinically proven functional products across haircare, skincare, and oral care with scalable manufacturing, we aim to become a global partner for high-performance personal care brands.&#8221;<\/p>\n<p>About KM Pharmaceutical Co., Ltd.<\/p>\n<p>KM Pharmaceutical Co., Ltd. is a Korea-based manufacturer specializing in skincare, oral care, and functional personal care products. With dual manufacturing facilities and over 25 years of experience, the company provides OEM\/ODM and private label solutions to global partners.<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p><span class=\"legendSpanClass\">SEOUL, South Korea<\/span>, <span class=\"legendSpanClass\">March 25, 2026<\/span> \/PRNewswire\/ &#8212; KM Pharmaceutical Co., Ltd. (KOSDAQ: 225430), a leading K-beauty manufacturer specializing in skincare, oral care, and private label OEM\/ODM production, is strengthening its global position by expanding into high-value functional product categories across haircare, skincare, and oral care.<\/p>\n<p>Expansion into High-Value Functional Product Categories<\/p>\n<p>KM Pharmaceutical is strategically expanding its product portfolio to focus on functional and OTC-driven categories with strong global demand.<\/p>\n<p>In haircare, the company is developing products targeting:<\/p>\n<ul type=\"disc\">\n<li>Hair loss symptom relief (functional scalp care)<\/li>\n<li>Scalp inflammation soothing<\/li>\n<li>Scalp barrier strengthening<\/li>\n<\/ul>\n<p>In skincare, the company is strengthening its functional cosmetic lineup with:<\/p>\n<ul type=\"disc\">\n<li>Brightening (whitening) solutions<\/li>\n<li>Anti-wrinkle and firming products<\/li>\n<li>Skin barrier repair and strengthening<\/li>\n<li>Anti-inflammatory and soothing formulations for sensitive skin<\/li>\n<\/ul>\n<p>In oral care, KM Pharmaceutical is expanding its OTC-focused portfolio with:<\/p>\n<ul type=\"disc\">\n<li>Teeth whitening solutions<\/li>\n<li>Gum disease prevention products<\/li>\n<li>Gingivitis and\u00a0periodontitis prevention formulations<\/li>\n<\/ul>\n<p>These categories reflect the company&#8217;s strategic direction toward high-efficacy, clinically positioned products that align with global consumer demand for functional and results-driven personal care.<\/p>\n<p>Dual-Facility Manufacturing Platform Supporting\u00a0Skincare and OTC Production<\/p>\n<p>KM Pharmaceutical operates two specialized production facilities in Korea:<\/p>\n<ul type=\"disc\">\n<li>An OTC manufacturing facility focused on oral care products, including toothpaste and functional personal care<\/li>\n<li>A cosmetics manufacturing facility dedicated to\u00a0skincare and beauty product development<\/li>\n<\/ul>\n<p>This infrastructure enables the company to deliver both cosmetic and OTC products under one integrated system, supporting global partners seeking scalable and compliant manufacturing solutions.<\/p>\n<p>Rapid Expansion in\u00a0Skincare OEM\/ODM with International Contracts<\/p>\n<p>Skincare continues to be a key growth driver for KM Pharmaceutical&#8217;s global business.<\/p>\n<p>The company recently secured:<\/p>\n<ul type=\"disc\">\n<li>A\u00a0KRW 1 billion annual skincare supply agreement with General Brands<\/li>\n<li>A new\u00a0skincare manufacturing partnership with Thailand-based ADMI<\/li>\n<li>Ongoing collaborations with multiple domestic and international partners<\/li>\n<\/ul>\n<p>Proven Global Manufacturing Experience with Leading Brands<\/p>\n<p>KM Pharmaceutical has established strong credibility through partnerships with globally recognized brands.<\/p>\n<p>The company has:<\/p>\n<ul type=\"disc\">\n<li>Produced oral care products under an exclusive long-term license for\u00a0Pororo the Little Penguin<\/li>\n<li>Manufactured and distributed products in Korea for\u00a0TheraBreath<\/li>\n<li>Previously manufactured toothpaste for Close-Up under\u00a0Unilever<\/li>\n<li>Currently producing toothpaste for\u00a0Weleda<\/li>\n<\/ul>\n<p>Fully Integrated\u00a0K-Beauty Manufacturing Platform<\/p>\n<p>KM Pharmaceutical operates a vertically integrated system covering:<\/p>\n<ul type=\"disc\">\n<li>R&amp;D and formulation<\/li>\n<li>OEM\/ODM manufacturing<\/li>\n<li>Packaging and mass production<\/li>\n<li>Global export and supply<\/li>\n<\/ul>\n<p>This end-to-end capability enables faster time-to-market, consistent quality, and scalable production for international partners.<\/p>\n<p>25 Years of Experience with Public Market Transparency<\/p>\n<p>Founded in 2001, KM Pharmaceutical has over 25 years of manufacturing experience.<\/p>\n<p>Since its KOSDAQ listing in 2018, the company has maintained audited financial transparency and governance aligned with public market standards.<\/p>\n<p>Internal Brand Success Demonstrating Product Competitiveness<\/p>\n<p>KM Pharmaceutical continues to validate its R&amp;D capabilities through its proprietary brands.<\/p>\n<p>Zerocipe, the company&#8217;s flagship brand, achieved the No.1 ranking in the shampoo category at Olive Young, recording peak daily sales exceeding KRW 100 million.<\/p>\n<p>The company has also expanded internationally through a distribution partnership with Cosway, targeting Southeast Asian markets.<\/p>\n<p>Balanced Growth Strategy: Recurring Revenue + Brand Upside<\/p>\n<p>KM Pharmaceutical is executing a dual-track strategy:<\/p>\n<ul type=\"disc\">\n<li>B2B Growth: Expanding OEM\/ODM partnerships<\/li>\n<li>B2C Expansion: Scaling proprietary brands through global channels<\/li>\n<\/ul>\n<p>Positioned as a Scalable Global Functional Beauty &amp; OTC Platform<\/p>\n<p>Brian Baik, CEO of KM Pharmaceutical stated:<\/p>\n<p>&#8220;KM Pharmaceutical is evolving beyond a traditional OEM\/ODM manufacturer into a functional beauty and OTC platform. By combining clinically proven functional products across haircare, skincare, and oral care with scalable manufacturing, we aim to become a global partner for high-performance personal care brands.&#8221;<\/p>\n<p>About KM Pharmaceutical Co., Ltd.<\/p>\n<p>KM Pharmaceutical Co., Ltd. is a Korea-based manufacturer specializing in skincare, oral care, and functional personal care products. With dual manufacturing facilities and over 25 years of experience, the company provides OEM\/ODM and private label solutions to global partners.<\/p>\n<p><!-- \/wp:html --><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[5,7],"tags":[],"class_list":["post-52311","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cision-pr-newswire","category-cision-pr-newswire-en"],"_links":{"self":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/52311","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=52311"}],"version-history":[{"count":0,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/52311\/revisions"}],"wp:attachment":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=52311"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=52311"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=52311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}